Infective Otitis Media — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for infective otitis media. 30 active patents protecting 3 drugs from 1+ originators. First major cliff: 2027. Daily refresh.

3
Approved drugs
30
Active US patents
60/100
Avg vulnerability
—
Annual revenue covered

Originators in Infective Otitis Media

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Generic (originally Merck) 29 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating infective otitis media. Each bar = one year. Y-axis scaled to peak year (9 patents).

2
26
3
27
2
28
6
30
1
32
9
34
1
36
3
37
1
39
1
41

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Decadron
dexamethasone
 Generic (originally Merck) 15 46 — 2027-12-19
Amoxil
amoxicillin
 Generic (originally Beecham/GSK) 14 58 — 2026-12-08
Suprax
CEFIXIME
 — 1 75 — 2028-12-14

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
8299052 Amoxil method of use 85 2027-05-07
8778924 Amoxil method of use 80 2026-12-08
9233112 Suprax method of use 75 2028-12-14
11931463 Amoxil method of use 75 2034-02-12
11878011 Amoxil method of use 75 2042-05-27
8357394 Amoxil formulation 65 2026-12-08
8101582 Decadron method of use 63 2027-12-19
7795316 Decadron method of use 63 2028-08-03
9050263 Amoxil method of use 62 2034-02-12
11135172 Amoxil method of use 62 2034-02-12

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
7977488 Amoxil composition of matter 18 2030-04-10
7977488 Amoxil composition of matter 18 2030-04-10
10537585 Decadron formulation 25 2037-12-18
10159683 Decadron formulation 25 2034-05-23
10799642 Decadron formulation 31 2032-05-11
8409606 Decadron formulation 31 2030-05-14
8450287 Decadron formulation 38 2027-12-19
10238606 Amoxil formulation 42 2034-02-12
10022502 Decadron method of use 45 2034-06-22
10028965 Decadron method of use 45 2034-05-23

Related